methylprednisolone has been researched along with Osteogenic Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broomé-Karlsson, A; Nilsson, A | 1 |
| al Sabagh, M; Bataini, JP; Delattre, JY; Poisson, M | 1 |
| Rizzo, SC | 1 |
1 review(s) available for methylprednisolone and Osteogenic Sarcoma
| Article | Year |
|---|---|
[Cerebral necrosis found 13 years after irradiation of osteosarcoma of the cranial vault].
Topics: Adolescent; Brain; Female; Head and Neck Neoplasms; Humans; Methylprednisolone; Necrosis; Osteosarcoma; Radiation Injuries; Risk Factors; Time Factors | 1990 |
2 other study(ies) available for methylprednisolone and Osteogenic Sarcoma
| Article | Year |
|---|---|
Influence of steroid hormones on the carcinogenicity of 90Sr.
Topics: Animals; Bone Neoplasms; Cocarcinogenesis; Estradiol; Female; Methylprednisolone; Mice; Mice, Inbred CBA; Nandrolone; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Strontium Radioisotopes; Time Factors | 1976 |
[Use of delayed-action high-dosage parenteral 6-methyl-prednisolone in oncology].
Topics: Adolescent; Adult; Aged; Appetite; Bone Neoplasms; Delayed-Action Preparations; Drug Evaluation; Female; Hodgkin Disease; Humans; Injections, Intramuscular; Lung Neoplasms; Lymphatic Metastasis; Male; Methylprednisolone; Middle Aged; Neoplasms; Osteosarcoma | 1974 |